Finding 963373 (2023-004)

Material Weakness
Requirement
N
Questioned Costs
-
Year
2023
Accepted
2024-03-28

AI Summary

  • Core Issue: There was a material weakness in internal controls regarding compliance with federal inspection requirements for the HOME Investment Partnership Program.
  • Impacted Requirements: Inspections were not conducted on time as mandated by CFR Title 24 Part 92.504(d), leading to noncompliance.
  • Recommended Follow-Up: Strengthen procedures to ensure timely inspections for all properties to comply with federal standards.

Finding Text

Material Weakness in Internal Control over Compliance and Material Noncompliance 2023-004 HOME Investment Partnership Program, ALN. 14.239 Award Period: July 1, 2022 – June 30, 2023 Compliance Requirement: Special Tests and Provisions Criteria or Specific Requirement: The Code of Federal Regulations (CFR) Title 24 Part 92.504(d) states that during the period of affordability, the participating jurisdiction must perform on-site inspections of HOME-assisted rental housing to determine compliance with the property standards of § 92.251 and to verify the information submitted by the owners in accordance with the requirements of § 92.252. The inspections must be in accordance with the inspection procedures that the participating jurisdiction establishes to meet the inspection requirements of § 92.251. Condition and Context: For one (1) out of nine (9) inspections selected for testing in our audit sample, the inspection was not conducted within the required timeframe in accordance with federal requirements. Questioned Costs: None Cause: Procedures were not in place to perform inspections timely for all inspections. Effect: Noncompliance with the federal grant program occurred. Repeat Finding: No. Recommendation: We recommend procedures be strengthened to perform inspections timely for all inspections. Views of Responsible Officials: Management agrees with the finding.

Categories

Special Tests & Provisions Material Weakness Internal Control / Segregation of Duties

Other Findings in this Audit

  • 386922 2023-001
    Significant Deficiency
  • 386923 2023-001
    Significant Deficiency
  • 386924 2023-001
    Significant Deficiency
  • 386925 2023-001
    Significant Deficiency
  • 386926 2023-002
    Significant Deficiency
  • 386927 2023-002
    Significant Deficiency
  • 386928 2023-002
    Significant Deficiency
  • 386929 2023-002
    Significant Deficiency
  • 386930 2023-003
    Material Weakness
  • 386931 2023-004
    Material Weakness
  • 963364 2023-001
    Significant Deficiency
  • 963365 2023-001
    Significant Deficiency
  • 963366 2023-001
    Significant Deficiency
  • 963367 2023-001
    Significant Deficiency
  • 963368 2023-002
    Significant Deficiency
  • 963369 2023-002
    Significant Deficiency
  • 963370 2023-002
    Significant Deficiency
  • 963371 2023-002
    Significant Deficiency
  • 963372 2023-003
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
21.027 Coronavirus State and Local Fiscal Recovery Funds $10.34M
14.239 Home Investment Partnerships Program $1.70M
84.425 Education Stabilization Fund $1.17M
93.778 Medical Assistance Program $681,540
84.010 Title I Grants to Local Educational Agencies $420,218
10.555 National School Lunch Program $328,529
84.367 Improving Teacher Quality State Grants $208,383
84.027 Special Education_grants to States $204,317
84.048 Career and Technical Education -- Basic Grants to States $164,208
14.231 Emergency Solutions Grant Program $140,764
84.365 English Language Acquisition State Grants $131,434
10.553 School Breakfast Program $111,780
16.922 Equitable Sharing Program $97,791
97.044 Assistance to Firefighters Grant $78,315
84.424 Student Support and Academic Enrichment Program $57,266
10.579 Child Nutrition Discretionary Grants Limited Availability $19,809
84.173 Special Education_preschool Grants $19,552
14.218 Community Development Block Grants/entitlement Grants $11,413
16.607 Bulletproof Vest Partnership Program $3,617
84.196 Education for Homeless Children and Youth $2,798
93.103 Food and Drug Administration_research $2,520